Steven A Markel sold $2.8M of MKL
director at MARKEL CORP. 1,330 shares at an average of $2,119.12, traded Dec 11, 2025, filed Dec 15, 2025.
Score components
- +15RoleDirector
- +25Trade size$2.8M at market
- 0Share of holdings soldSold 2.2% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.9%, 3m -9.5%, 6m -14.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001096343-25-000159, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -64 | $2,100.00 | $134k | 61,634 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -50 | $2,103.55 | $105k | 61,584 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -70 | $2,108.27 | $148k | 61,514 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -40 | $2,112.03 | $84k | 61,474 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -120 | $2,114.99 | $254k | 61,354 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -100 | $2,116.18 | $212k | 61,254 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -201 | $2,117.37 | $426k | 61,053 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -24 | $2,118.37 | $51k | 61,029 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -51 | $2,120.65 | $108k | 60,978 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -173 | $2,121.69 | $367k | 60,805 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -10 | $2,123.05 | $21k | 60,795 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -32 | $2,125.00 | $68k | 60,763 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -75 | $2,126.00 | $159k | 60,688 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -190 | $2,127.26 | $404k | 60,498 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -10 | $2,128.00 | $21k | 60,488 | Dec 15, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock10b5-1 | -120 | $2,129.98 | $256k | 60,368 | Dec 15, 2025 |
Related signals
Other insiders at MARKEL CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | MKLsell MARKEL CORP | Greta J Harris director | $140k 76 shares | -11% | |
| 53Moderate | MARKEL CORP | Diane Leopold director | $269k 150 shares | +7% | |
| 47Moderate | MARKEL CORP | A. Lynne Puckett director | $102k 57 shares | +4% | |
| 37Weak | MKLsell MARKEL CORP | Simon Wilson EVP and CEO, Markel Insurance | $208k 100 shares | -4% | |
| 18Weak | MARKEL CORP | Steven A Markel director | $357k 170 shares | -0% | |
| 44Moderate | MARKEL CORP | Simon Wilson CEO, Markel Insurance | $155k 75 shares | -4% | |
| 31Weak | MKLsell MARKEL CORP | Meade P. Grandis CAO and Controller | $149k 75 shares | -21% | |
| 39Weak | MARKEL CORP | Greta J Harris director | $168k 90 shares | -12% | |
| 21Weak | MKLbuy MARKEL CORP | Lawrence A Cunningham director | $46k 25 shares | +3% | |
| 45Moderate | MARKEL CORP | Meade P. Grandis CAO and Controller | $765k 400 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.